Introduction
============

Autism is characterised by deficits in reciprocal social interaction, disrupted verbal and non-verbal communication, and restricted interests and repetitive behaviours, and is known to have a strong genetic component.[@b1] [@b2] Cytogenetic studies indicate that ∼3--4% of autism patients have chromosomal imbalances[@b3; @b4; @b5] that include maternal 15q11q13 duplications (∼1--2% of patients) and deletions of 2q37, 22q11.2 and 22q13.3.[@b4] [@b6] Higher resolution approaches using array comparative genomic hybridisation (aCGH) and single nucleotide polymorphism microarrays have recently identified submicroscopic copy number variants (CNVs),[@b7; @b8; @b9; @b10] including recurrent microdeletions and duplications of 16p11.2 that have been reported in ∼1% of autism patients.[@b8] [@b11] [@b12] Importantly, the discovery of chromosomal abnormalities and CNVs has led to the identification of rare intragenic mutations through deep resequencing of autism candidate genes, including *NLGN3* and *NLGN4*,[@b13] *NRXN1*,[@b10] [@b14] [@b15] *SHANK3*[@b16; @b17; @b18] and *CNTNAP2*.[@b19; @b20; @b21] Although mutations in these genes account for only a small proportion of individuals with autism, they nonetheless provide insight into potential biological mechanisms that may underlie autism, such as synaptic dysfunction and abnormal brain connectivity.[@b22] [@b23]

Here, we report the case of a boy with autism, microcephaly, and other dysmorphic features in whom aCGH detected a ∼3.3-Mb interstitial deletion in chromosome 1p34.2p34.3 that contains ∼43 genes, including Regulating synaptic membrane exocytosis protein 3 (*RIMS3*), a gene previously shown to be dysregulated in autism subjects.[@b24] We examined the role of *RIMS3* in 512 unrelated autism subjects by performing mutation analyses to look for putative functional variants.

Clinical report
===============

The boy (LP99-105) was born at term to healthy and unrelated parents, and appeared normal except for right hydronephrosis and vesicoureteral reflux, which both resolved. His head circumference was normal at birth, but decelerated after 7 months and subsequently followed a curve at or just below −2 SD ([figure 1A](#fig1){ref-type="fig"}). His early motor development was normal, but he walked late at 16 months. He used his first few words at 15 months and slowly increased to 50--75 words by 2.5 years, but then progressively stopped using almost all speech by 3 years.

![(A) The patient\'s head circumference (HC) was normal at birth, but decelerated after 7 months and subsequently followed a curve at −3 SD. Y axis shows HC size in both centimetres and inches. X axis indicates age. The top and bottom dashed curves represent HC at +2 SD (98%) and −2 SD (2%), respectively, in relation to the mean (50%) HC curve (solid). Serial HC measurements for the patient are represented as red dots. (B) The patient\'s facial appearance is normal at 1 year of age. (C) At 10 years the boy has subtle dysmorphism with a long narrow face and deep set or sunken eyes.](jmg065821.f1){#fig1}

On examination, he had a normal facial appearance at 1 year ([figure 1B](#fig1){ref-type="fig"}), but by 10 years he had a long narrow face and deep set or sunken eyes ([figure 1C](#fig1){ref-type="fig"}). His general and neurological examinations were normal, including good motor coordination. Serial exams between 2 and 10 years all demonstrated poor social communication including poor eye contact and limited interactive play, striking anxiety, difficulty with transitions, constant chewing, short attention span, poor sleep pattern, and repetitive activities such as bouncing on an exercise ball. Brain magnetic resonance imaging (MRI) at 1 year demonstrated mildly prominent extra-axial spaces, but was otherwise normal. Serial audiograms done during his first several years of life demonstrated normal hearing.

He was diagnosed with autistic disorder at age 4 years at a university based assessment clinic for children with developmental disorders. On the Autism Diagnostic Observation Schedule--Generic (ADOS-G),[@b25] he exceeded the autism cut-off score on the communication, social, and communication plus social domains, thus meeting the criterion for an Autism Diagnostic Observation Schedule--Generic classification of autism (domain scores: communication 6; social 12; stereotyped behaviours and restricted interests 4). The diagnosis was further supported by meeting the cut-off scores of autism on the Autism Diagnostic Interview--Revised (ADI-R)[@b26] with his mother as the informant. More widespread developmental abnormalities were documented at 4 years based on an overall standard score of 28 on the Scales of Independent Behavior--Revised,[@b27] a parent report measure of adaptive behaviour. This falls in the "limited to very limited" range, equivalent to behaviours at 18 months in typically developing children.

During the subsequent 6 years, he has not regained any language skills, except for using several signs inconsistently. He developed a striking fear response when placed in a car at age 9 years that has persisted for more than 3 years. Chromosome analysis and polymerase chain reaction (PCR) based fragile X testing were normal, and no other genetic tests were done. This boy is not part of the Autism Genetics Resource Exchange (AGRE, Los Angeles, California, USA) consortium (<http://www.agre.org/>).

Subjects and methods
====================

Autism and control subjects
---------------------------

We obtained phenotype data and DNA from the 1p34 deletion proband under a protocol approved by the Institutional Review Board at the University of Chicago. The remaining autism probands selected for this study were a subset of the AGRE subjects that were collected with informed consent and institutional review board approval.[@b28] The AGRE cohort consisted of 512 unrelated autism subjects (151 females and 355 males) from 84 simplex and 428 multiplex families. Subjects who missed criteria for autism on the ADI-R were classified as having 'Not Quite Autism' (NQA) if their scores on each ADI-R behavioural domain were within one point of the criteria, or if they met criteria for each domain except for age of onset \<3 years of age. Fragile X testing was performed in all families and a subset of families had karyotyping and CNV analyses performed. Genomic DNA from control subjects (225 females and 237 males) was obtained from the National Institute of Mental Health Human Genetics Initiative control sample set. These subjects were screened for Axis I mental health disorders and none were reported as having autism. A summary of the ethnic origins of the autism patients and control subjects is provided in supplementary table 1.

Array comparative genomic hybridisation
---------------------------------------

We performed aCGH on the patient using a 19-K whole genome tiling path bacterial artificial chromosome (BAC) microarray as previously described.[@b7] We refined the size of the 1p34.2p34.3 microdeletion using the Illumina 610-Quad BeadChip microarray (Illumina Inc, San Diego, California, USA, <http://www.illumina.com/>).

Fluorescence in situ hybridisation (FISH) and microsatellite analyses
---------------------------------------------------------------------

FISH and microsatellite analyses were performed using standard techniques (supplementary materials).

DNA amplification and sequencing
--------------------------------

PCR primers were designed using MIT Primer3 with M13 forward and reverse tails added to each primer to facilitate high throughput DNA sequencing (supplementary table 2). DNA amplification and purification were performed using standard conditions and protocols (supplementary materials).

Pathway analyses
----------------

A *RIMS3* network was predicted through the use of Ingenuity Pathways Analysis software (Ingenuity Systems Inc, Redwood City, California, USA; <http://www.ingenuity.com/>). To generate this network, a dataset of known autism genes (ie, focus genes) was uploaded into the application. The Ingenuity Pathways Knowledge Base was used to identify interactions between the focus genes and other gene objects. The network was then algorithmically generated based on their connectivity. The network was comprised of 'nodes'---that is, the gene or gene product, connected by 'edges' that are biological relationships supported by at least one publication. The network was then trimmed to show a refined network with minimal connections between the autism focus genes.

Protein predictions
-------------------

We used several applications to predict the effects of missense substitutions on protein function including SIFT (Sorting Intolerant From Tolerant, <http://sift.jcvi.org/>),[@b29] PolyPhen (Polymorphism Phenotyping, <http://coot.embl.de/PolyPhen/>),[@b30] and SNAP (<http://cubic.bioc.columbia.edu/services/snap/>).[@b31]

Results
=======

Discovery of a 1p34.2p34.3 microdeletion in a child with autism and microcephaly
--------------------------------------------------------------------------------

We performed aCGH using a 19-K whole genome tiling path BAC microarray in patient LP99-105, and detected a ∼3.3 Mb deletion in chromosome 1p34.2p34.3 that extended from RP11-769L8 to RP11-483I17 and included ∼47 genes ([figure 2A](#fig2){ref-type="fig"}). The microdeletion was not detected in 372 control subjects analysed on the same BAC array platform.[@b7] FISH studies confirmed the deletion in the proband ([figure 2B](#fig2){ref-type="fig"}), and microsatellite analysis demonstrated that the deletion was de novo (data not shown). We used the Illumina 610-Quad BeadChip microarray to refine the breakpoints to approximately chr1:39,794,296 and chr1:43,058,974 (UCSC Genome Browser, <http://genome.ucsc.edu>; Build 36.1; accessed November 2008), reducing the size of the microdeletion by ∼56 kb and identifying ∼43 genes within the deleted region.

![(A) Array comparative genome hybridisation (aCGH) using a bacterial artificial chromosome (BAC) microarray demonstrates a deletion in chromosome 1p34.2. The aCGH plot shows the log~2~ ratio of the patient versus reference DNA on the vertical axis. Each individual BAC is represented as a single blue dot and the horizontal axis shows the position of each BAC along chromosome 1. The deletion of 1p34.2 is indicated by an arrow pointing to a vertical line of dots. Interrogation of the UCSC genome browser for the microdeletion region in this region identifies ∼47 RefSeq genes (shown below aCGH plot). Known copy number variants (CNVs) (orange blocks) and Indels (green blocks) are reported in the Database of Genomic Variants track. (B) Fluorescence in situ hybridisation (FISH) analysis confirms the deletion 1p34.2 aCGH results. The distal breakpoint boundary is indicated where RP11-67o15 (green arrows) shows two normal signals while RP11-120G12 (red arrow) shows a single signal in the interphase nucleus.](jmg065821.f2){#fig2}

We reviewed the Database of Genomic Variants (<http://projects.tcag.ca/variation/>, Build 36; accessed November 2008) to determine whether any CNVs in the general population were present in the 1p34.2p34.3 microdeletion region. No CNVs encompassed the entire deleted region, but we did find several smaller blocks of CNVs ([figure 2A](#fig2){ref-type="fig"}). The largest of these blocks, independently characterised by four groups (variations 3289, 4219, 5487 and 8322), was ∼435 kb in size and contained 11 genes (*PPIE*, *PPT1*, *TRIT1*, *OXCT2*, *MYCL1*, *BMP8B*, *MFSD2*, *RLF*, *CAP1*, *TMCO2*, and *ZMPSTE24*). Both copy number gains and losses of this region were reported in the general population.

Identification and characterisation of *RIMS3* as a candidate gene for autism
-----------------------------------------------------------------------------

We hypothesised that rare mutations in one or more genes in the 1p34.2p34.3 microdeletion region---excluding the 11 in the ∼435 kb polymorphic block---may be responsible for autism in other affected individuals as well. Interrogation of these ∼32 genes using published literature and online expression databases identified *RIMS3* as the most promising candidate. Network analysis using Ingenuity Pathways Analysis software demonstrated that *RIMS3* directly interacts with the protein tyrosine phosphatase *PPFIA3* that belongs to the liprin-α gene family (supplementary figure 1). *RIMS3* was also associated with many other autism candidate genes through an indirect interaction with *FMR1*, mutations of which cause fragile X syndrome (OMIM 300624).

To test the hypothesis that mutations in *RIMS3* underlie the autism phenotype, we sequenced all *RIMS3* coding regions, their associated splice sites, and the 5′ and 3′untranslated regions in 512 unrelated autism patients. We also sequenced these regions in 462 control subjects to capture the natural genetic diversity of *RIMS3* in the general population. In the autism samples, we identified five novel coding variants (three non-synonymous and two synonymous) that were absent in control subjects and not reported in public DNA databases (Ensembl, <http://www.ensembl.org/> and dbSNP, <http://www.ncbi.nlm.nih.gov/projects/SNP/>, both accessed February 2009) ([table 1](#tbl1){ref-type="table"}). Demographic data for these five subjects, including sex, race, and ethnicity, are provided in [table 1](#tbl1){ref-type="table"}. We also identified a 5′untranslated region variant as well as one intronic variant located 30 bp upstream of the third exon. We found five different sequence changes in the controls ([table 1](#tbl1){ref-type="table"}).

###### 

*RIMS3* mutation screening identifies putative mutations associated with autism

  Phenotype   Individual ID   Family ID    Sex      Race            Ethnicity                Location   Amino acid   Nucleotide position[\*](#table-fn1){ref-type="table-fn"}   chrl            Protein prediction   Conservation[‡](#table-fn3){ref-type="table-fn"}   Transmission   Autism frequency[†](#table-fn2){ref-type="table-fn"}   Control frequency[†](#table-fn2){ref-type="table-fn"}   Sibling status                                                                                                             Sequence context (neg.stand, 5′→3′)
  ----------- --------------- ------------ -------- --------------- ------------------------ ---------- ------------ ---------------------------------------------------------- --------------- -------------------- -------------------------------------------------- -------------- ------------------------------------------------------ ------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- -------------------------------------
  Autism      HI2273          AU0379-04    Female   White           Not Hispanic or Latino   5′UTR      NA           23661 G\>A                                                 chrl:40880225   NA                   Conserved                                          Undetermined   1/402                                                  0/399                                                   DNA unavailable                                                                                                            GATTCATCCA\[G/A\]GTCTGATGTG
  Autism      HI2183          AU0783-04    Male     More than one   Not Hispanic or Latino   Exon 1     p.N3H        80346                                                      chrl:40880176   NA                   Conserved                                          Maternal       1/404                                                  0/399                                                   Absent in one affected sibling (AU0783-05)                                                                                 CCATGTTTAA\[C/T\]GGGGAGCCAG
  Autism      HI2536          AU09343-01   Male     White           Hispanic or Latino       Intron 3   NA           32619 G\>C                                                 chrl:40871297   NA                   Conserved                                          Paternal       1/444                                                  0/458                                                   Present in one affected sibling (AU0934-302)                                                                               GTTGAGTGGG\[G/C\]TAATGGTGAC
  Autism      HI0515          AU0247-03    Male     White           Not Hispanic or Latino   Exon 4     p.E177A      92948                                                      chrl:40867574   Not tolerated        Conserved                                          Maternal       1/453                                                  0/1161                                                  Present in one NQA sibling (AU0247-04)                                                                                     GAAGTGATTG\[A/C\]AGCTCGGGGC
  Autism      H11965          AU0679-03    Male     White           Not Hispanic or Latino   Exon 5     p.A207T      93358                                                      chrl:40867164   Tolerated            Highly conserved                                   Paternal       1/451                                                  0/459                                                   Absent in one affected sibling (AU0679-03)                                                                                 GGCCTGCTTG\[G/A\]CCAAGAAGAA
  Autism      HI0686          AU0125-04    Female   White           Not Hispanic or Latino   Exon 6     p.M260V      95597                                                      chrl:40864925   Tolerated            Conserved                                          Paternal       1/432                                                  0/459                                                   Present in one affected sibling (AU0125-3)                                                                                 GGCCCAGATC\[A/C\]TGCTGGACGA
  Autism      HI2305          AU0841       Male     Black or AA     Not Hispanic or Latino   Exon 6     p.S267S      95620                                                      chrl:40864902   NA                   Highly conserved                                   Maternal       1/432                                                  0/459                                                   Absent in one affected (AU0841-05) and one unaffected (AU0841-03) sibling; present in one unaffected sibling (AU0841-06)   TGGACCTCAG\[C/T\]GCCGCGGTCA
  Control     05C51058        --           Male     Black of A A    Unknown                  Intronic   NA           23622 C\>T                                                 chrl:40880294   NA                   Not conserved                                                     0/440                                                  1/460                                                   --                                                                                                                         CCCAAGGTCA\[C/T\]GCAGCTAGGA
  Control     05C41407        --           Male     White           Unknown                  Exon 2     R84R         86240                                                      chrl:40874282   NA                   Highly conserved                                                  0/440                                                  1/460                                                   --                                                                                                                         GCAACATCCG\[C/T\]CGGAGCACGG
  Control     05C51267        --           Male     White           Unknown                  Exon 2     R85R         86243                                                      chrl:40874279   NA                   Highly conserved                                                  0/440                                                  1/460                                                   --                                                                                                                         ACATCCGCCG\[G/C\]AGCACGGAGA
  Control     05C42678        --           Male     White           Unknown                  Exon 2     T120M        86347                                                      chrl:40874175   Not tolerated        Highly conserved                                                  0/440                                                  1/460                                                   --                                                                                                                         TCCGACGGCA\[C/T\]GTGCGTGCAG
  Control     05C43397        --           Male     White           Unknown                  Exon 4     1162V        92902                                                      chrl:40867620   Tolerated            Highly conserved                                                  0/453                                                  1/460                                                   --                                                                                                                         AGATGTGCA\[A/G\]TTGCCATCAT

Based on AL031289.

Number of individuals, not chromosomes.

Four species were compared (human, rhesus macaque, mouse, and pufferfish (Fugu)). Conservation is described at the amino acid and nucleotide levels for coding and non-coding variants. Highly conserved, conserved across all four species; Conserved, conserved between human, rhesus, and mouse; Not conserved, conserved only between human and macaque or human only.

Sequencing of parental DNA indicated that all five coding variants were inherited. We performed segregation analysis in families by sequencing each variant in affected and/or unaffected siblings. In two multiplex families (AU0247 and AU0125, [figure 3](#fig3){ref-type="fig"}), the variant segregated with the autism phenotype in siblings. In family AU0247, the maternally inherited p.E177A variant first identified in patient HI0515 was also present in a sibling with NQA, but absent in 1161 control subjects. We reviewed available phenotype data on the carrier mother, who had depression and symptoms of bipolar disorder and anxiety. She also had a repaired cleft palate and had received speech language therapy (the father had received speech language therapy as well). The heterozygous sib had a ventricular septal defect that closed spontaneously by 1 year and diastasis recti. CNV analysis on this family provided on the AGRE website ruled out known CNVs associated with autism, including microdeletion of 22q11.

![Mutation analysis of *RIMS3* identifies two missense variants that segregate with autism and autism related phenotypes. (A) The pedigree for family AU0247 shows that the p.E177A missense variant is present in a patient with autism (AU0247-03), in a sibling with Not Quite Autism (NQA) (AU0247-04), and in the mother who presents with psychiatric symptoms. Chromatograms indicate the presence of the A/C substitution. The SIFT program predicted the p.E177A substitution to be deleterious. (B) The pedigree for family AU0125 shows that the p.M260V missense variant is present in two siblings with autism (AU0125-03 and AU0125-04) as well as in the father who presents with psychiatric symptoms, including obsessive--compulsive disorder (OCD). Chromatograms indicate the presence of the A/G substitution. The variant is not predicted to affect protein function.](jmg065821.f3){#fig3}

The p.E177A substitution, which changes a glutamic acid (acidic and polar) to an alanine (neutral and nonpolar) residue, was predicted to be deleterious according to both the SIFT and SNAP programs. We determined the extent of conservation of the E177 residue by comparing it against the RIMS3 primary protein structure of other species (<http://genome.ucsc.edu/>, hg 18, accessed February 2009). E177 was conserved among all 18 eutherian mammals with data available, but differs from the presumed ancestral Q177 residue found in six species of fish.

In family AU0125, the p.M260V exon 6 variant identified in patient HI0686 was not predicted to affect protein function by any of the three in silico protein programs. The carrier father had obsessive--compulsive disorder, depression, anxiety, and attention deficit hyperactivity disorder. The presence of psychiatric disorders in parents of children with autism has been observed previously in several studies,[@b32; @b33; @b34] consistent with the hypothesis of multiple genes with small additive effects in autism. By parental report, both children had compulsions and rituals, and difficulties with changes in routines and their environment. A summary of phenotype information for the affected siblings in families AU0247 and AU0125 is provided in [table 2](#tbl2){ref-type="table"}, with detailed phenotype data for all members of families AU0247 and AU0125 included in the supplementary materials. Phenotypic data for the other three families with coding variants (AU0783, AU0679, and AU0841) were not available.

###### 

Phenotype analysis

                                            AU012503             AU012504              AU024703        AU024704
  ----------------------------------------- -------------------- --------------------- --------------- ---------------
  Mutation                                  M260V                M260V                 E177A           E177A
  Sex                                       Male                 Female                Male            Male
  Ethnicity                                 Non-Hispanic         Non-Hispanic          Non-Hispanic    Non-Hispanic
  Race                                      White                White                 White           White
  ADI-R                                                                                                
   Age (years) at ADI-R                     10                   7                     6               3
   Social domain                            11                   19                    24              9
   Communication-verbal domain              17                   13                    20              16
   Restricted, repetitive behavior domain   11                   12                    5               3
   Classification                           Autism               Autism                Autism          NQA
   Age of 1st words (months)                12                   12                    48              36
   Age of 1st phrases (months)              16                   14                    54              38
   Any language regression                  No                   No                    No              No
   Overall level of language                Phrase speech        Phrase speech         Phrase speech   Phrase speech
   Any regression of other skills           No                   H, P, SH, M           No              No
   Anxiety                                  None                 \+                    None            \+
   Aggression                               +++                  +++                   \+              \+
   Overactivity                             \+                   \+                    \+              \+
   History of seizures                      No                   Possible              No              No
   Age first steps (months)                 14                   11                    11              13
   Gait                                     Abnormal             Abnormal              Hx abnormal     Unusual
   Coordination impairment (Gross/Fine)     GF                   GF                    None            GF
   Savant skills                            Memory               Drawing               Drawing         --
   ADOS classification                      Spectrum             Autism                Autism          Autism
  Physical measures and abnormalities                                                                  
   Age (years) at physical examination      12                   10                    7               5
   Birth weight (g)                         4309                 3600                  3374            2920
   Height (cm)                              154.9                139.7                 50              --
   Percentage                               61                   42                    \<3             
   Weight (kg)                              80                   31.8                  --              --
   Percentage                               97                   29                                    
   Head circumference (cm)                  57.7                 51.8                  --              49.4
   Head circumference (%)                   98                   53                    --              27
   Ear length (cm)                          6                    5.7                   5.5             5.1
  Functioning/psychiatric                                                                              
   Age (years) at IQ testing                12                   10                    7               5
  Verbal IQ                                 126                  --                    --              --
   Non-verbal IQ                            94                   107                   110             --
   Depressive symptoms                      No                   Yes                   No              No
   OCD symptoms                             Yes                  Dx                    Yes             No
   Other diagnosis                          Anxiety, ADHD        Bipolar, ADHD                         
   Stimulants (current)                                          Adderal                               
   Other medications (current)              Paxil, risperidone   Depakote, clonidine   Naltrexone      none
   ADHD                                     Dx                   Dx                    Yes             Yes
   Sleep problems                           0--1 yo              0--1 yo               1--2 yo         Missing
   Asst. reproduction                       None                 None                  None            None
   Handedness                               Right                Right                 Right           Right

ADHD, attention deficit hyperactivity disorder; ADI-R, Autism Diagnostic Interview-Revised; ADOS, Autism Diagnostic Observation Schedule; H, loss of purposive hand use; M, motor; NQA, not quite autism; OCD, obsessive--compulsive disorder; P, play and imagination; SH, self help.

We also sequenced *RIMS3* in the boy with the 3.3 Mb deletion to test the hypothesis that the microdeletion might unmask a recessive allele on the non-deleted chromosome. We did not identify any putative functional coding variants.

In control subjects, we identified four coding variants that were distinct from those identified in autism patients; one of these was predicted to affect protein function ([table 1](#tbl1){ref-type="table"}). Three of the four variants were located in exon 2, a region that did not contain any of the five variants reported in the autism subjects. The fourth variant, p.I162V, was located in the same coding region in exon 4 that harboured the p.E177A substitution. Interestingly, the subject harbouring this variant presented with symptoms of obsessive--compulsive disorder. Phenotypic data on the parents of the control subjects were not available.

Discussion
==========

We report a boy with postnatal microcephaly, minor dysmorphic features, mental retardation and autism associated with a 3.3 Mb deletion involving ∼43 genes in chromosome 1p34.2p34.3. The deletion is large and de novo, leading us to hypothesise that it is responsible for his abnormal phenotype. However, the specific genes responsible for different features of the 1p34.2p34.3 deletion phenotype are unknown.

Only a few patients with interstitial deletions of 1p34.2p34.3 have been reported. The closest match is the recent report of a Dutch boy with a 4.1 Mb deletion that completely overlaps the deletion we report, with loss of an additional 14 genes including the glucose transporter gene *SLC2A1*.[@b35] Overall, he has a more severe phenotype than our patient with severe mental retardation and hypotonia, 'profound' microcephaly and epilepsy, as well as heterotopia and ponto-cerebellar atrophy on brain imaging. The more severe phenotype is not surprising given the severe phenotype associated with loss of *SLC2A1* alone (OMIM 606777). Three other patients have been reported with deletions involving this general region. One boy with a much larger ∼17 Mb visible deletion had severe developmental delay, poor growth, and microcephaly.[@b36] Two sibs who inherited a juxtaposed inversion (inv 1p22.3p34.1) and deletion (1p34.1p34.3) of this region presented with behaviour disorders, although their intelligence and appearance were normal.[@b37] A detailed genotype--phenotype analysis involving 1p34.2p34.3 in these patients is provided in the supplementary materials.

Based on the reported altered regulation of *RIMS3* in autism[@b24] (see below) and our pathway analysis, we hypothesise that mutations in the synaptic protein RIMS3 is the primary contributor to the autism phenotype in the 1p34.2p34.3 microdeletion patient. A large number of autism related genes are involved in synapse function, neuronal cell adhesion, or both.[@b38] Several of these have been implicated in autism based on cytogenetic rearrangements, CNVs or rare mutations, including *NLGN3* and *NLGN4*,[@b13] *NRXN1*,[@b10] [@b14] [@b15] *SHANK3*,[@b16; @b17; @b18] and *CNTNAP2*.[@b19; @b20; @b21] RIMS3 belongs to the RIM protein family that function as important components of the presynaptic machinery for synaptic vesicle fusion and neurotransmitter release.[@b39] Expression analysis of *RIMS3* in the rat demonstrated that it is exclusively expressed in the brain[@b40] and protein studies indicated that RIMS3 was detected only in rostral brain regions but not in spinal cord, hindbrain, or midbrain.[@b40] Overexpression of *RIMS3* has been demonstrated to greatly facilitate Ca^2+^ triggered exocytosis, supporting a role for *RIMS3* as a regulator of exocytosis in the synaptic membrane.[@b40] One recent study demonstrated that expression of *RIMS3* is dysregulated in lymphoblastoid cells from autism patients with either maternal duplications of 15q11q13 or fragile X syndrome.[@b24] Others have reported increased expression of *RIMS3* in schizophrenia,[@b41] [@b42] a neuropsychiatric disorder hypothesised to have shared genetic aetiology with autism.[@b43] Thus, several lines of evidence converge to support the hypothesis that abnormal *RIMS3* function due to chromosomal imbalances or rare mutations may underlie autism. However, we cannot exclude the possibility that other genes within or near the ∼ 3.3 Mb 1p34.2p34.3 deletion may contribute to autism.

To address whether *RIMS3* point mutations underlie autism, we sequenced the complete *RIMS3* coding region in 512 unrelated autism patients. In total, five coding variants were identified in autism patients that were absent in ∼460 controls. None of these variants were de novo and all were inherited with no bias between maternal versus paternal transmission. We used several in silico programs to assess the functional impact of these variants on protein function, and identified one variant (p.E177A) that was predicted to be deleterious. This variant segregated with the autism phenotype in two sibs, was not identified in 1161 controls, and is highly conserved among eutherian mammals.

The p.E177A substitution resides in a C~2~B domain that is known to bind to several proteins including α-liprins, SNAP-25, and voltage gated calcium channels.[@b44] [@b45] However, the critical residues for some of these interactions are downstream of p.E177 and this amino acid is not conserved among the RIM family of proteins.[@b40] α-Liprins are known to interact directly with CASK, a calcium/calmodulin dependent serine protein kinase that belongs to the membrane associated guanylate kinase family. CASK regulates the trafficking, targeting and signalling of numerous presynaptic proteins including neurexins, APBA1 (Mint1) and ion channels,[@b46] and is also implicated in brain development.[@b47] Interestingly, a C~2~B domain is also found in Doc2-α (Double C2-like domains, α), a protein that belongs to the same superfamily as RIMS3. *DOC2A* is one of ∼24 genes located within the 16p11.2 microdeletion-duplication region that has recently been detected in ∼1% of patients with autism.[@b8] [@b11] [@b12]

Although the p.E177A variant was not found in a large number of controls and was predicted to be deleterious using SIFT and SNAP, further studies are needed to prove whether the p.E177A substitution is pathogenic or not, as protein simulation programs do not substitute for experimental confirmation.[@b29] [@b48] Only two of the three in silico methods we used predicted a deleterious effect from the p.E177A variant. This is not surprising, given that each program varies in methodology, including differences in classification approaches (eg, machine learning vs rule based systems) and input information (eg, sequence data, functional annotation, protein structure, solvent accessibility).[@b29] [@b31] We also identified one variant in a control subject that was predicted to be deleterious. Only limited phenotype data are available for this subject, so we cannot determine whether it is a benign or weakly pathogenic variant. Detailed phenotypic assessment of this subject would help distinguish between these possibilities.

In summary, our data demonstrate that heterozygous loss of one or more of the 43 genes located within a ∼3.3 Mb interval on chromosome 1p34.2p34.3 are associated with abnormal development, including mental retardation, postnatal microcephaly and autism. Furthermore, our data suggest but do not prove conclusively that *RIMS3* is an autism causative or contributory gene. To our knowledge, this is the first study to suggest that mutations in a RIM protein may underlie autism or other neurodevelopmental disorders. The identification of putative mutations in *RIMS3* is consistent with the identification of CNVs and intragenic mutations of other pre- and post-synaptic proteins in patients with autism, and lends further support to the hypothesis that abnormalities in synaptic development and function underlie autism in some (and perhaps many) patients. Functional studies of *RIMS3* variants such as p.E177A should provide additional insight into the role of pre-synaptic proteins in autism. Finally, the rare association of microcephaly and autism suggests that other gene(s) in the region are associated with brain growth.
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